Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component

Abstract

A bivalent approach for targeting polo-like kinase 1 (Plk1) kinase domain and polo-box domain simultaneously provides dramatically enhanced affinity ligands of Plk1 even with the use of a non-selective ATP-competitive inhibitor.